Accès gratuit
Numéro
Med Sci (Paris)
Volume 25, Numéro 3, Mars 2009
Page(s) 247 - 252
Section M/S revues
DOI https://doi.org/10.1051/medsci/2009253247
Publié en ligne 15 mars 2009
  1. Beauchemin N, Draber P, Dveksler G, et al. Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res 1999; 252 : 243–9.
  2. Gray-Owen SD, Blumberg RS. CEACAM1: contact-dependent control of immunity. Nat Rev Immunol 2006; 6 : 433–46.
  3. Létourneau S, Beauchemin N. Rôles des antigènes carcino-embryonnaires dans la cancérisation et la progression tumorale. Med Sci (Paris) 1997; 13 : 483–91.
  4. Hemmila E, Turbide C, Olson M, et al. Ceacam1a−/− mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59. J Virol 2004; 78 : 10156–65.
  5. Najjar SM. Regulation of insulin action by CEACAM1. Trends Endocrinol Metab 2002; 13 : 240–5.
  6. Poy MN, Yang Y, Rezaei K, et al. CEACAM1 regulates insulin clearance in liver. Nat Genet 2002; 30 : 270–6.
  7. Xu E. Targeted disruption of Ceacam1 promotes diet-induced hepatic steatosis and insulin resistance. Endocrinology 2009 (sous presse).
  8. Formisano P, Najjar SM, Gross CN, et al. Receptor-mediated internalization of insulin. Potential role of pp120/HA4, a substrate of the insulin receptor kinase. J Biol Chem 1995; 270 : 24073–7.
  9. Horst A, Wagener C. CEA-related CAMs. Hum Exp Pharmacol 2004; 165 : 283–341.
  10. Simeone DM, Ji B, Banerjee M, et al. CEACAM1, a novel serum biomarker for pancreatic cancer. Pancreas 2007; 34 : 436–43.
  11. Kunath T, Ordoñez-Garcia C, Turbide C, Beauchemin N. Inhibition of colonic tumor cell growth by biliary glycoprotein. Oncogene 1995; 11 : 2375–82.
  12. Phan D, Cheng CJ, Galfione M, et al. Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. Cancer Res 2004; 64 : 3072–8.
  13. Beauchemin N, Kunath T, Robitaille J, et al. Association of biliary glycoprotein with protein tyrosine phosphatase SHP-1 in malignant colon epithelial cells. Oncogene 1997; 14 : 783–90.
  14. Izzi L, Turbide C, Houde C, Kunath T, Beauchemin N. Cis-determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function. Oncogene 1999; 18 : 5563–72.
  15. Leung N, Turbide C, Balachandra B, et al. Intestinal tumor progression is promoted by decreased apoptosis and dysregulated Wnt signaling in Ceacam1−/− mice. Oncogene 2009; 27 : 4943–53.
  16. Leung N, Turbide C, Olson M, et al. Deletion of the carcinoembryonic antigen-related cell adhesion molecule 1 (Ceacam1) gene contributes to colon tumor progression in a murine model of carcinogenesis. Oncogene 2006; 25 : 5527–36.
  17. Liu W, Wei W, Winer D, et al. CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastase s. Oncogene 2007; 26 : 2747–58.
  18. Obrink B. On the role of CEACAM1 in cancer. Lung Cancer 2008; 60 : 309–12.
  19. Ebrahimnejad A, Streichert T, Nollau P, et al. CEACAM1 enhances invasion and migration of melanocytic and melanoma cells. Am J Pathol 2004; 165 : 1781–7.
  20. Ergün S, Kilik N, Ziegeler G, et al. CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. Mol Cell 2000; 5 : 311–20.
  21. Horst AK, Ito WD, Dabelstein J, et al. Carcinoembryonic antigen-related cell adhesion molecule 1 modulates vascular remodeling in vitro and in vivo. J Clin Invest 2006; 116 : 1596–605.
  22. Kilic N, Oliveira-Ferrer L, Wurmbach JH, et al. Pro-angiogenic signaling by the endothelial presence of CEACAM1. J Biol Chem 2005; 28 : 2361–9.
  23. Müller MM, Singer BB, Klaile E, et al. Transmembrane CEACAM1 affects integrin-dependent signaling and regulates extracellular matrix protein-specific morphology and migration of endothelial cells. Blood 2005; 105 : 3925–34.
  24. Tilki D, Irmak S, Oliveira-Ferrer L, et al. CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer. Oncogene 2006; 25 : 4965–74.
  25. Oliveira-Ferrer L, Tilki D, Ziegeler G, et al. Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer. Cancer Res 2004; 64 : 8932–8.
  26. Kilic N, Oliveira-Ferrer L, Neshat-Vahid S, et al. Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1. Blood 2007; 110 : 4223–33.
  27. Nagaishi T, Pao L, Lin SH, et al. SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. Immunity 2006; 25 : 769–81.
  28. Donda A, Mori L, Shamshiev A, et al. Locally inducible CD66a (CEACAM1) as an amplifier of the human intestinal T cell response. Eur J Immunol 2000; 30 : 2593–603.
  29. Chen Z, Chen L, Qiao SW, et al. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits proximal TCR signalling by targeting ZAP-70. J Immunol 2008; 180 : 6085–93.
  30. Markel G, Lieberman N, Katz G, et al. CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity. J Immunol 2002; 168 : 2803–10.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.